Skip to main Content
Go to Corporate Home Page
Corporate Profile
About Us
Analyst Coverage
Company Presentations
News & Events
Press Releases
Company Events
Stock Quote
Corporate Governance
Governance Documents
Board of Directors
Management Team
SEC Filings
Investor Resources
FAQs
Email Alerts
Contact IR
Empowering the genetic medicines revolution with a differentiated PCR-enabled platform for large-scale, synthetic DNA production.
Nasdaq (APDN)
